- August 7, 2018 | BY
Neuroimmunology, immunopsychiatry and the cusp of a new era in treating diseases of the central nervous system
- August 3, 2018 | BY
Preemptive strike against planetary microbes, using adult stem cells to treat PD, and major strides in creating built-to-order lungs.
- August 2, 2018 | BY
Five tips on how to save your drug development dollars and be smart with your bioanalytical studies
- July 31, 2018 | BY
Just where will Brexit leave patients, pharmaceutical manufacturers, and testing companies that do business in the EU and UK?
- July 27, 2018 | BY
What’s right and wrong with Shark Week, updates from the Alzheimer’s Association International Conference including a new antibody drug that shows hints of promise, and how the liver plays a role in identifying ALS
- July 25, 2018 | BY
How a South Dakota researcher is trying to arrest a rare disease by studying its origins. A Q&A with Sanford Research scientist Jill Weimer.
- July 24, 2018 | BY
From dosing to choice of animal, five key considerations to think about when designing ototoxicity studies for drugs
- July 20, 2018 | BY
A promising new procedure for curing trachoma, the connection between digital media and ADHD, and can we use a blood test to detect melanoma?
- July 18, 2018 | BY
Updated test guidelines lead to confusion and extra cost, but better results
- July 17, 2018 | BY
Checkpoint inhibitors have led to remarkable responses in a small percentage of patients. Could combining them with other drugs improve the odds?